The lack of CD57 downregulation on GBM-SCs upon their differentiation also suggests that CD57, which has been preferentially found on stem-like rather than differentiated Ewing sarcoma [22] and neuroblastoma cells [21], is not a bona fide CSC marker for GBM. Here, B3GAT1 is linked to glioblastoma.